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ABSTRACT
RISK FACTORS ASSOCIATED WITH THE DEVELOPMENT OF PREECLAMPSIA
IN ADOLESCENT PREGNANCY. Amy L. Winkelsteim, Sara J. Marder and Chaur-Dong
Hsu. Department of Obstetrics/Gynecology, Yale University, School of Medicine, New Haven,
CT.
This study aimed to identify risk factors associated with the development of preeclampsia during
adolescent pregnancy. We performed a retrospective cohort study of 435 pregnant adolescent women, age
< 18 years, between January 1, 1994 and April 26, 1997. Demographic data, gynecologic age (GA) (years
between menarche and conception), chronologic age (CA), prepregnancy body mass index (PBM1), weight
gain, medical, surgical, obstetric, gynecologic, social and family history were abstracted from records.
Preeclampsia (PE) was defined as hypertensive proteinuria. PBM1 was defined as weight/height (kg/m2).
Data were analyzed using contingency table, simple and multiple logistic regression analyses. Data were
expressed as odds ratios with 95% confidence intervals (OR, 95% Cl). Fifty-six out of 435 pregnant
adolescent women (12.9%) developed PE. Simple logistic regression analysis revealed that GA (OR:Q.82,
95% Cl: 0.69-0.96, p=0.02) and CA (OR:0.81, 95% Cl: 0.67-0.99, p=0.04) were negatively correlated with
PE. PBMI (OR: 1.11,95% Cl: 1.05-1.17, p=0.0003), prepregnancy weight (OR: 1.01, 95% Cl: 1.01-1.02,
p=0.0008), total weight gain (OR: 1.046, 95% Cl: 1.02-1.07, p=0.0001), weight gain per week (OR: 2.40,
95% CE1.42-4.06, p=0.001) and urinary tract infection (OR: 2.00, 95% Cl:1.03-3.89,p=0.04) were
positively correlated with PE. When GA< 4 years (OR: 2.12, 95%CI: 1.20-3.75, p=0.01), CA< 17 years
(OR: 1.99, 95% Cl: 1.10-3.62, p=0.02) or PBMI >30 obese adolescents were at significantly increased risk
for PE. After adjustment for significant factors, the risk for PE with GA <4 years (OR:2.22, 95% 0:1.1214.407, p=0.02), CA< 17 years ( OR:2.85, 95%CI: 1.374-5.889, p=0.005), GA <4 years and CA<17 years
(OR: 3.27, 95% Cl: 1.627-6.552, p=0.0009) or PBMI >30 (OR:4.54, 95% 0:1.46-14.14, p=0.009)
remained significant. The incidence of PE is higher in pregnant adolescent women than in the general
population. Low gynecologic and chronologic age and obesity prior to pregnancy are strong risk factors for
PE in adolescent pregnancy.
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Introduction:
Preeclampsia is a leading cause of maternal and neonatal morbidity and mortality
worldwide (1). Second only to embolism, it is an important cause of maternal death (2).
Preeclampsia places both the mother and the fetus at increased risk for life threatening
complications during the antepartum, intrapartum and postpartum periods. The HELLP
syndrome, (hemolysis, elevated liver enzymes, low platelets), a severe complication of
preeclampsia, can compromise the health of both the mother and the fetus (3).
Additionally, preeclampsia is a major cause of preterm delivery, fetal growth restriction
and perinatal mortality (4).
Preeclampsia has a reported incidence of 2.6 % to 22.3 % (5,6). This wide range
in incidence is largely due to differences in definition of preeclampsia and study design,
e.g. different selection criteria for a study population and differing methods of statistical
analysis of data. Despite the high incidence of preeclampsia and the potentially severe
consequences of the disease for both mother and child, the etiology of the disease still
remains unknown. Although preeclampsia has been studied extensively and many
hypotheses regarding etiology exist, the specific etiology of the disease and the risk
factors associated with the disease remain poorly understood.
Over the years, researchers have explored many different hypotheses regarding
the pathophysiology of preeclampsia. Currently, five major hypotheses exist: 1) placental
ischemia, 2) very low-density lipoprotein versus toxicity- preventing activity, 3) immune
maladaptation, 4) genetic imprinting and finally, 5) a systemic inflammatory response (7,
8). Six decades ago. Page proposed that the placental component of preeclampsia is
mediated by reduced placental perfusion (9). Norwitz et al. also hypothesized that the
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primary event in the development of preeclampsia is a failure of the second wave of
trophoblast invasion from 16-20 weeks' gestation (10). This failure of trophoblast
invasion may be responsible for the destruction of the muscularis layer of the spiral
arteries. Norwitz et al. further assert that as the pregnancy progresses and the metabolic
demand of the fetoplacental unit increases, the incompletely remodeled spiral arteries are
unable to accommodate the needed increase in blood flow. This failure of
accommodation and resulting ischemia may lead to further placental dysfunction and
what is recognized as preeclampsia clinically (10). Building on this hypothesis, Roberts
et al. assert that this abnormal placental perfusion results in the production of circulating
factor(s) that alter endothelial cell function (11). The injured endothelium then activates
the coagulation cascade resulting in the loss of the ability of the endothelial cells to act as
a barrier. Consequently, extravasation of extravascular fluid follows, and the endothelial
cells are unable to buffer the effect of the normally circulating pressors. This final
breakdown in endothelial cell function leads to what is clinically known as preeclampsia
(11). Additionally, Krauss et al. showed that elevated soluble intercellular adhesion
molecule-1 (ICAM-1) and vascular cell adhesion molecule- 1 (VCAM-1) are associated
with preeclampsia (12). These findings of increased levels of ICAM-1 and VCAM-1
further support the concept of endothelial cell involvement in the pathogenesis of
preeclampsia.
The second major hypothesis currently being evaluated is the very low-density
lipoprotein versus toxicity-preventing activity theory (7). This hypothesis is built on the
premise that the body mobilizes nonesterified fatty acids in an attempt to compensate for
the increased energy demand during pregnancy. It is hypothesized that the mobilization
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of nonesterified fatty acids reduces the antitoxic activity of albumin to a point at which
very- low density lipoprotein toxicity is expressed and can then cause damage.
Another possible basis for the pathophysiology of preeclampsia is the immune
maladaptation hypothesis (7). This hypothesis suggests that immune maladaptation in the
body causes abnormal placentation with only shallow invasion of spiral arteries by the
endovascular cytotrophoblast cells. The trophoblast subsequently fails to induce the
physiologic dilation and remodeling of spiral arteries (7). Additionally, an increased
decidual release of cytokines, proteolytic enzymes, and free radicals may mediate
endothelial cell dysfunction (7, 13). Many examples in the literature support the role of
the immune system in the etiology of preeclampsia. Dekker suggests that the increased
incidence of urinary tract infection associated with preeclampsia could be due to this
immune maladaptation (14). Dekker further proposes that not only urinary tract
infections but any type of infection may result in an increased production of
inflammatory products including certain cytokines, free radical species and proteolytic
enzymes (14). Additionally, Klonoff- Cohen et al. conducted a case- control study
comparing the contraceptive and reproductive histories of primiparous women with and
without preeclampsia (15). In this study there was a 2.37 fold increased risk of
preeclampsia for users of barrier contraceptives that prevent exposure to sperm (95% Cl:
1.01-5.58) (15). These findings suggest that there is a protective role of repeated sperm
exposure in decreasing the risk of preeclampsia. This protective role implicates a
possible role of the immune system in the development of preeclampsia. Robillard et al.
also show that in primigravidae and multigravidae women the length of sexual
cohabitation before conception was inversely related to incidence of preeclampsia

4

(pO.OOOl) lending additional support to the immune maladaptation hypothesis (16).
Smith et al. reported that there is an increased incidence of preeclampsia in pregnancies
that are the result of donor insemination (relative risk: 1.85, 95% Cl: 1.20-2.85) (17).
Each of these findings reveals that repeated sperm exposure and subsequent immune
system desensitization might be protective against the development of preeclampsia.
The genetic imprinting hypothesis suggests that the development of preeclampsiaeclampsia is based on either a single recessive gene or a dominant gene with incomplete
penetrance (7). After studying the incidences of preeclampsia and eclampsia in 147
sisters, 248 daughters, 74 granddaughters and 131 daughters-in-law of women with
preeclampsia, Chesley and Cooper concluded that preeclampsia is likely determined by a
single recessive gene acting in the affected women instead of in their fetuses (18). They
determined that the frequency of this gene is 0.25. Additionally, Lie et al found that a
woman who was pregnant by a partner who has already fathered a preeclamptic
pregnancy in another woman was at twice the risk of developing preeclampsia in her own
pregnancy (19). Lie et al further assert that paternal genes, as expressed by the fetus,
may contribute to the mother's risk of preeclampsia. They also state that it is unlikely
that purely maternal inheritance, specifically by mitochondrial DNA, is involved in
preeclampsia (19).
A fifth main hypothesis, newly presented by Redman et al., suggests that the
endothelial cell dysfunction and preeclampsia are part of a more generalized intravascular
inflammatory reaction (8). This study argues that preeclampsia is the result of the
decompensation of a universal maternal intravascular inflammatory response to
pregnancy. This decompensation may be the result of either a very strong stimulus or a
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very strong maternal response to a stimulus. Redman et al consider preeclampsia as the
extreme end in the range of maternal maladaptation to pregnancy.
Many other hypotheses exist pertaining to the pathophysiology of preeclampsia.
After finding that in a group of 101 patients with history of severe early-onset
preeclampsia 24.7% had a protein S deficiency, 16.0% had activated protein C resistance,
17.7% had hyperhomocysteinemia and 29.4% had the presence of anticardiolipin
antibodies, Dekker et al suggested a role of coagulopathies in preeclampsia (20). It
appears that preeclampsia likely comprises a group of heterogeneous causes of maternal,
fetal, and placental derivation (21).
Despite the absence of a clear understanding regarding the etiology of
preeclampsia, extensive research studies have identified many risk factors for the
development of the disease. Risk factors include nulliparity, which increases the risk of
preeclampsia by 3.8 -5.4 times, (16, 22-26), multiple gestations (risk ratio: 4:1)(22, 27),
advanced maternal age (22, 28), preeclampsia in a previous pregnancy (OR: 10.8, 95%
Cl: 1.2- 29.1) (25), family history of pregnancy-induced hypertension (risk ratio of 5:1)
(18), urinary tract infections (OR: 5.3, 95% Cl: 2.9-9.7) (23), high pre-pregnancy body
mass index (23, 25, 29, 30), in utero exposure to DES (23,30), a family history of
hypertension (25), use of a barrier contraceptive (15), length of sexual cohabitation) 16),
donor intrauterine insemination (17), chronic hypertension (risk ratio: 10:1) (31), diabetes
mellitus (risk ratio: 2:1) (24), chronic renal disease (risk ratio: 20:1) (32),
antiphospholipid syndrome (risk ratio: 10:1) (33) and angiotensinogen gene T235:
homozygous (risk ratio 20:1) and heterozygous (risk ratio 4:1) (34). Those who live at
high altitudes also have an increased incidence of preeclampsia when compared to those
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living at sea level (35). Palmer et al believe that this finding is secondary to the
interference of the high altitude with the normal vascular adjustments needed during
pregnancy. They assert that this may be analogous to other conditions that also decrease
uteroplacental oxygen delivery such as preeclampsia (35). Asthma during pregnancy has
also been shown to increase the risk of preeclampsia suggesting that both preeclampsia
and asthma might be caused by a third factor affecting vascular smooth muscle reactivity
(OR: 2.52, 95% Cl: 1.47-4.35, p=0.0008) (36). Additionally, clinically normal patients
with elevated mid-trimester levels of urine beta-core fragment of human chorionic
gonadotropin are at increased risk for the subsequent development of preeclampsia (37).
Controversy exists regarding the finding that African American race is a risk
factor. Mittendorf et al established in a nested, case-control study that black race was
positively associated with preeclampsia (OR: 1.5, 95% Cl; 1.1-1.9) while Savitz and
Zhang found that in their study population, blacks and whites had similar risks of disease
(22, 23).
Other behaviors and factors are protective against the development of
preeclampsia. Cigarette smoking appears to have a protective effect in the development
of preeclampsia (22, 23, 38, 39). Klonoff- Cohen et al. conducted a case-control study
comparing the smoking histories of 110 nulliparous preeclamptic women and 115 healthy
nulliparous women aged 15-35 years delivering at North Carolina Memorial Hospital
(39). They found that after adjustment for work during pregnancy, alcohol use,
medication use, contraceptive choices and family history of preeclampsia there was a
negative association between cigarette smoking during pregnancy and preeclampsia (OR:
0.71, 95% Cl: 0.33-1.50) (39). In another case- control study, Mittendorf et al also found

7

a negative association between cigarette use and preeclampsia after multiple logistic
regression analysis (OR: 0.6, 95% Cl: 0.5-0.8) (23). A history of spontaneous abortions
also appears to be protective in multiparous women (OR: 0.09, 95% Cl: 0.02-0.48) (25).
Just as there are contradictory findings regarding the risk factors for preeclampsia,
even greater disagreement exists regarding the finding that adolescents are at an increased
risk for the development of preeclampsia. Many studies have found that mothers with a
young maternal age are at increased risk for developing preeclampsia (6, 40-44). Other
studies, however, report that there is no increase in the risk of preeclampsia associated
with young maternal age, and there may even be an increase in risk as the maternal age
increases (45-52). Despite this controversy surrounding the specific risk of developing
preeclampsia for adolescents, there are very few studies focusing only on the adolescent
population and any unique qualities that may predispose this group to develop
preeclampsia. Since approximately one million teenagers become pregnant in the United
States each year, it is important to gain a better understanding of the specific risk factors
associated with the development of preeclampsia in an adolescent population in order to
improve our ability to predict who is at risk for developing preeclampsia and provide
better preventive strategies (53). The following retrospective cohort study, therefore,
aims to evaluate risk factors associated with the subsequent development of preeclampsia
in adolescents.

Statement of Purpose:
The present retrospective cohort study seeks to identify the risk factors associated
with the development of preeclampsia in adolescents. The aim is to use this information
to improve the current understanding of the etiology and pathogenesis of this disorder
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and facilitate identification of adolescent patients at risk for the development of
preeclampsia.
Materials and Methods:
Subjects were selected from all patients who delivered a live singleton at YaleNew Haven Hospital during the time period between January 1, 1994 and April 26, 1997.
Patients with pre-existing renal disease, chronic hypertension, diabetes mellitus, a
pregnancy facilitated by in vitro fertilization, a multiple gestation or age over eighteen
years were excluded from our study. Only patients receiving prenatal care in the Yale
University Women’s Center, the Hill Health Center and Community Health Care Plan
were included.
A standard form devised by the investigators was used to abstract information
from the 435 charts that fit the criteria specified above (Appendix A). The Human
Investigation Committee of the Yale University School of Medicine authorized the
review of charts (Protocol # 9052; Appendix B). Maternal demographic information
included age, race, marital status, employment status, type of insurance, clinic service
and whether level of education was age appropriate. Information on personal habits
included cigarette use, alcohol use and use of illicit drugs. Data abstracted regarding past
and present medical and obstetric history included gravidity, parity, age at menarche,
gynecologic age, pre-pregnancy height and weight, pre-pregnancy body mass index,
weight gain during pregnancy, gestational age at first visit, number of prenatal visits,
gestational age at delivery, gestational diabetes during pregnancy, one hour GCT test
results, HIV status if known, positive culture for Group B Streptococcus during
pregnancy, hyperemesis gravidarum during this pregnancy, sexually transmitted diseases
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diagnosed during this and prior pregnancies, history of induced or spontaneous abortions,
urinary tract infections during this pregnancy, maximum biood pressure recorded during
each trimester of this pregnancy and presence of preeclampsia during prior or current
pregnancy. Neonatal data included birth weight, gestational age at delivery, incidence of
low birth weight and preterm births, and neonatal morbidity and mortality.
Pre-pregnancy body mass index was calculated using the Quetelet index (weight
(kg)/ meters2) incorporating the pre-pregnancy weight reported by the patient during the
first prenatal visit and the height measured and recorded at the first prenatal visit.
Gynecologic age was defined as chronological age at conception minus the patient’s age
at menarche (54). A diagnosis of preeclampsia was given if patients had two blood
pressure measurements taken after twenty weeks gestational age and obtained at least six
hours apart that were > 140 mmHg systolic or > 90 mmHg diastolic. Additionally, in
order to receive the diagnosis of preeclampsia patients had to have at least two urine
dipstick measurements obtained at least six hours apart with greater than or equal to 2+
protein. Patients were further classified as having severe preeclampsia if they met any of
the following criteria: systolic blood pressure > 160 mmHg or diastolic blood pressure
>110 mmHg, proteinuria > 5g/ 24 hours, elevated serum creatinine, grand mal seizures,
pulmonary edema, oliguria < 500ml/24 hours, microangiopathic hemolysis,
thrombocytopenia, hepatocellular dysfunction, intrauterine growth retardation or
oligohydramnios, or headache, visual disturbances, epigastric or right-upper quadrant
pain (55).
In the univariate analysis, categorical variables were tested with the chi square or
Fisher exact test and continuous variables with two-tailed Student t test. Statistical
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significance was defined as a P value < 0.05. Multiple logistic regression analysis was
then used to determine whether the factors found to be statistically significant by
univariate analysis remained significant after controlling for potentially confounding
variables. Data was expressed as odds ratios with 95% confidence intervals. All
statistical analyses were performed using StatView 5.0 for Power Macintosh.
Results:
Part I:
During the time period between January 1, 1994 and April 26, 1997, 435 women
eighteen years or younger who fit the above specified criteria delivered at Yale-New
Haven Hospital. Table 1 presents the maternal demographic characteristics of these
women.
The average chronologic age of the population was 16.2 years with a standard
deviation of 1.4 and a standard error of 0.07. Our study population was 60.2% African
American, 20.5% Hispanic and 19.3% Caucasian. Ninety-seven percent of this
population was unmarried while the remaining three percent were married. 70.8% of
these adolescents were unemployed. 80.7% of these young mothers received Medicaid as
their insurance. 87.4% of the population who delivered at Yale-New Haven Hospital
during this time period also received their prenatal care in the Women’s Center. The
remaining 9.2% and 1.8% of our population received their prenatal care at the Hill Health
Center and Community Health Care Plan respectively. Information regarding where the
subject received her prenatal care was not available for eleven of the four hundred and
thirty-five charts (1.6 %). 55.6% of this study population had an age appropriate
education level.

Table 1 Maternal Demographic Characteristics
Maternal Demographic Characteristics
Number
Average Chronologic Age

16.2 years

Percent (%)
Not applicable

Race
African American

262/435

60.2

Hispanic

89/435

20.5

Caucasian

84/435

19.3

Marital Status
Single
Married

422/435

97

13/435

3

Employment Status
308/435

70.8

351/435

80.7

Yale University Women’s Center

380/435

87.4

Hill Health Center

40/435

9.2

8/435

1.8

242/435

55.6

Unemployed
Medicaid
Prenatal Clinic Site

CHCP

Level of Education Age Appropriate
CHCP-Community Health Care Plan

Table 2 presents the pertinent medical history data from our population. The
average pre-pregnancy height of our population was 64.0 inches with a standard
deviation of 2.5 and a standard error of 0.1. Information on pre-pregnancy height for
forty-four of the 435 subjects was not found in the corresponding charts. The average
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pre-pregnancy weight of the subjects was 134.4 pounds with a standard deviation of 29.0
and a standard error of 1.5. Information on pre-pregnancy weight was not available for
fifty-three subjects. The average pre-pregnancy body mass index (BMI) was calculated
to be 23 kg/m2 with a standard deviation of 4.63. The pre-pregnancy BMI was not
calculated for sixty-four subjects given the corresponding lack of either pre-pregnancy
height or pre-pregnancy weight.
Table 2 Selected Maternal Medical Characteristics
Medical Characteristic

Value

Standard

Standard

Deviation

Error

Average Pre-Pregnancy Height

64.0A

2.5

0.1

Average Pre-Pregnancy

134.4b

29.0

1.5

23 c

4.63

Weight
Average Pre-Pregnancy BMI
BMI- Body Mass Index
Expressed in inches
expressed in pounds
expressed in kg/m

The information regarding past and present obstetric history is shown in Table 3.
69.9% of the population was nulliparous. The average age at menarche of the study
group was 11.8 years with a standard deviation of 1.47 and a standard error of 0.07. The
minimum age at menarche was eight years old and the maximum age was seventeen
years old. The average gynecologic age (GA) was 4.39 years with a standard deviation
of 1.79 and a standard error of 0.09 with a maximum age of 9 years. The average weight
gain during pregnancy was 27.05 pounds with a standard deviation of 13.48 and a
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standard error of 0.71. The average weight gain per week was 1.18 pounds with a
standard deviation of 0.53 and a standard error of 0.03. The average gestational age at
the first prenatal visit was 14.49 weeks with a standard deviation of 7.17 and standard
error of 0.36. The average number of prenatal visits was 9.70 with a standard deviation of
4.0 and a standard error of 0.20.
Table 3 Selected Maternal Obstetric Characteristics
Obstetric

Value

Standard Error

Deviation

Characteristic
Nulliparous

Standard

69.9%

Not applicable

Not applicable

11.80

1.47

0.07

Average GA (years)

4.39

1.79

0.09

Average weight

27.05

13.48

0.71

1.18

0.53

0.03

14 .49

7.17

0.36

9.70

4.00

0.20

Average age at
Menarche (years)

gain during
pregnancy (lbs)
Average weight
gain per week (lbs)
Average gestational
age at first prenatal
visit (weeks)
Average number of
prenatal visits
GA = Gynecologic Age
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Many women in our study experienced complications of pregnancy as seen in
Table 4. Two women (0.5%) developed gestational diabetes. Twenty-one women
(4.8%) had positive cultures for Group B Streptococcus (GBS) during pregnancy. Fortyfive women (10.3%) had at least one sexually transmitted disease (STD) diagnosed
during this pregnancy. Eighty-one women (18.6%) had and received treatment for a
urinary tract infection (UTI) during this pregnancy. Fifty-six women fit the criteria
previously cited for preeclampsia during this pregnancy. Our incidence of preeclampsia
in this population was 12.9%.
Table 4 Complications During Pregnancy
Complication
Gestational Diabetes

Number

Percent (%)

2/435

0.5

Positive Culture for GBS

21/435

4.8

Sexually Transmitted Disease

45/435

10.3

Urinary Tract Infection

81/435

18.6

Preeclampsia

56/435

12.9

Univariate statistical analysis with contingency table (chi square and Fisher
exact tests) or the Student t test as appropriate revealed that gynecologic age (GA),
chronologic age (CA), pre-pregnancy BMI, UTI, the total weight gain during pregnancy,
the pounds gained per week of pregnancy and pre-pregnancy weight were statistically
significant risk factors for the development of preeclampsia in adolescents during
pregnancy. Gynecologic age and chronologic age have a negative correlation with the
development of preeclampsia. Pre-pregnancy BMI, UTI, total weight gain during
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pregnancy, weight gain per week of pregnancy and pre-pregnancy weight were all
positively correlated with preeclampsia in adolescents. Table 5 reveals the specific Odds
Ratio (OR), 95% Confidence Interval (Cl) and p value for each variable after analysis by
simple logistic regression.
Table 5 Significant Risk Factors after Simple Logistic Regression
Risk Factor

Odds Ratio

95% Cl

P value

GA

0.82

0.69-0.96

0.02

CA

0.81

0.67-0.99

0.04

1.11

1.05-1.17

0.0003

2.00

1.03-3.89

0.04

1.046

1.02-1.07

0.0001

2.40

1.42-4.06

0.001

1.01

1.01-1.02

0.0008

Pre-Pregnancy BMI
UTI
Total Weight Gain
During Pregnancy
Weight Gain per
Week of Pregnancy
Pre-Pregnancy
Weight
GA- Gynecologic Age
UTI- Urinary Tract Infection

CA- Chronologic Age
BMI- Body Mass Index

After adjustment for significant factors, multiple logistic regression analysis
revealed that gynecologic age, pre-pregnancy BMI, weight gain per week of pregnancy
and the total weight gain during pregnancy remained significant for the development of
preeclampsia. The specific adjusted odds ratio and 95% confidence interval for each
variable is expressed in Table 6 below. Chronologic age and incidence of UTI during
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pregnancy were no longer significant after adjustment for significant factors with
multivariate logistic regression analysis.
Table 6 Statistical Significance after Multivariate Logistic Regression Analysis
Characteristic

Adjusted Odds

95 % Cl

P value

Ratio
Gynecologic Age

0.81

0.67 - 0.99

0.04

Pre-Pregnancy BMI

1.10

1.03 -1.18

0.01

Pre-Pregnancy

1.01

1.00- 1.02

0.01

2.19

1.27 - 3.76

0.004

1.04

1.02-1.06

0.001

Weight
Weight gain per
week of pregnancy
Total weight gain

Although both the amount of weight gained per week of pregnancy and the total
weight gain during pregnancy remained significant after multivariate logistic regression
analysis, we feel that the weight gained per week is a more accurate measure than the
total weight gain. This increased accuracy is due to the finding that women with
preeclampsia will have a higher weight gain during pregnancy than those without
preeclampsia. Subsequently, these same individuals with the greater total weight gain
will often deliver earlier than normal controls secondary to the complications of
preeclampsia, thus making the total weight gain not clinically significant and less
reliable.
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Part II:
After finding that a high pre-pregnancy BMI was positively associated with an
increased risk for the development of preeclampsia in adolescent pregnancies, we
attempted to further subcategorize pre-pregnancy BMI in order to determine if a specific
pre-pregnancy BMI was either protective against or predisposed an adolescent to the
development of preeclampsia. The study population was the same as that described in
the materials and methods section above. The sub-categorization of BMI, as defined by
Cnattingius et al, divides subjects into four distinct groups based on BMI as seen in Table
7 below.
Table 7 Classification by Pre-Pregnancy Body Mass Index
Classification

Body Mass Index Range15

Underweight/Lean

<20.0

Normal weight^

20.0-24.9

Overweight

25.0-29.9

Obese

>30.0

A Cnattingius, S, Bergstrom, R, Lipworth, L, Kramer, MS. Prepregnancy weight and the
risk of adverse pregnancy outcomes. N Engl J Med 1998; 338:147-52.
.
.
Body mass index is expressed in kg/m“
( This group will be used as the reference group in further analyses.
i)

1

Simple logistic regression analysis revealed that obese adolescents had a
significantly higher risk for the development of preeclampsia when compared to those
with a normal pre-pregnancy body mass index (OR: 4.4, 95% Cl: 1.8-10.9, p = 0.001).
The incidences of preeclampsia in women categorized as underweight, normal weight.

overweight and obese were 9.2%, 11.1%, 19.0% and 35.7%. Table 8 presents the crude
odds ratio, 95% confidence interval and p value for each subcategory.
Table 8 Simple logistic regression analysis of pre-pregnancy BMI for underweight,
overweight, and obese adolescents when compared to normal weight adolescents for
risk of preeclampsia
Category

Number

Percent (%)

Odds Ratio

95% Cl

Normal

188

50.0

1.0

Referent

Underweight

98

26.1

0.81

0.36-1.84

0.61

Overweight

63

16.8

1.88

0.87-4.09

0.11

Obese

27

7.2

4.44

1.81-10.9

0.001

P Value

weight

After adjustment for statistically significant factors with multiple logistic
regression analysis, the risk of developing preeclampsia with a pre-pregnancy BMI >30
kg/m2 remained significant (adjusted OR: 4.54, 95% Cl: 1.46 - 14.14, p = 0.009) while
being underweight or overweight remained insignificant. Adolescents with a pre¬
pregnancy BMI > 30 kg/m2 have a four-fold increased risk of developing preeclampsia
during pregnancy. Additionally, when the underweight and overweight adolescents were
compared to the normal weight adolescents, there was no significant increase in the risk
of developing preeclampsia nor was there any protective effect of being underweight.
Table 9 below shows the adjusted odds ratio, 95% Cl and p value for each subcategory
after multiple logistic regression analysis.
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Table 9 Multiple Logistic Regression Analysis of pre-pregnancy BMI for
underweight, overweight, and obese adolescents when compared to normal weight
adolescents for risk of preeclampsia
Number
Percent (%) Adjusted
Category
95% Cl
P Value
Odds Ratio
188

50.0

1.0

Referent

Underweight

98

26.1

0.83

0.35-1.96

0.67

Overweight

63

16.8

1.83

0.78-4.29

0.16

Obese

27

7.2

4.54

1.46-14.14

0.009

Normal
Weight

Part III:
Since simple logistic regression analysis revealed that gynecologic and
chronologic age were statistically significant risk factors for preeclampsia in adolescent
pregnancy, we attempted to determine which specific gynecologic and chronologic ages
put an adolescent at greater risk for the development of preeclampsia. Our initial
findings revealed that only gynecologic age remained statistically significant after
analysis with multivariate logistic regression. It was felt that the wide range of ages in
the chronologic age category, with fewer subjects at the lower end of the range, was
confounding to make the entire group less statistically significant. We, therefore, aimed
to isolate which age groups were at a higher risk for the development of preeclampsia.
The same study group as previously mentioned in the materials and methods
section was used. The information was abstracted from the appropriate charts using the
questionnaire in Appendix A.
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Groups of individuals with a gynecologic age and chronologic age below specific
cutoff values were analyzed using simple logistic regression analysis. A gynecologic age
less than 5 or 4 years was found to be a more specific cutoff value for identifying
individuals with a statistically significant risk of developing preeclampsia (OR: 1.83,
95% Cl 1.02-3.31, p = 0.04). Additionally, individuals with a chronologic age less than
17 or 16 years was a statistically significant cutoff value for the development of
preeclampsia in adolescents (OR: 1.99, 95% Cl: 1.10-3.62, p = 0.02). Table 10 shows
these results.
Table 10 Statistical Significance of Selected Gynecologic and Chronologic Ages by
Simple Logistic Regression Analysis
Variable'

Odds Ratio

95% Cl

F* value

GA < 5

1.84

1.02 - 3.31

0.04

GA < 4

2.12

1.20 - 3.75

0.01

CA< 17

1.99

1.10 - 3.62

0.02

CA < 16

1.93

1.08 - 3.47

0.03

A Gynecologic Age (GA) and Chronologic Age (CA) are expressed in years
After adjustment for significant factors, analysis with multiple logistic regression
revealed that a gynecologic age less than four years, chronologic age less than seventeen
years and a chronologic age less than sixteen years all remained significant risk factors
for developing preeclampsia during adolescent pregnancy. Furthermore, the cumulative
effect of analyzing gynecologic age with chronologic age increased the strength of the
association and the risk for developing preeclampsia. Those individuals with a
gynecologic age less than four years and a chronologic age less than seventeen years
appear to be at the greatest risk for developing preeclampsia, (adjusted OR: 3.27, 95%
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Cl: 1.627 - 6.552, p= 0.0009) as shown in table 11 below. Although an individual with a
chronologic age less than seventeen years or less than sixteen years appears to be at
increased risk for the development of preeclampsia, chronologic age less than seventeen
years was felt to be a more accurate predictor of preeclampsia as it is more inclusive.
Table 11 Statistical Significance of Gynecologic and Chronologic Ages by Multiple
Logistic Regression Analysis
95 % Cl
Variable^
Adjusted Odds
P Value
Ratio
GA < 4

2.22

1.121 -4.407

0.02

CA< 17

2.85

1.374- 5.889

0.005

CA< 16

2.06

1.039-4.074

0.039

GA < 5 and CA <

2.60

1.294-5.203

0.007

2.72

1.287-5.741

0.009

2.86

1.452 - 5.638

0.002

3.27

1.627 - 6.552

0.0009

16
GA < 4 and CA <
16
GA < 5 and CA <
17
GA< 4 and CA < 17

AGynecologic Age (GA) and Chronologic Age (CA) are expressed as years
In summary, our study found that individuals with a pre-pregnancy body mass
index greater than 30kg/m“, the individual's pre-pregnancy weight, the amount of weight
one gains per week during pregnancy, a chronologic age less than seventeen years, a
gynecologic age less than four years, a gynecologic age less than five years in addition to
a chronologic age less than sixteen or seventeen years, and a gynecologic age less than
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four years in addition to a chronologic age less than sixteen or seventeen years are each
significant risk factors for developing preeclampsia during pregnancy.
Discussion:
Our retrospective cohort study found that adolescents with a pre-pregnancy body
mass index > 30 kg/nr were 4.5 times more likely to develop preeclampsia during
pregnancy than those adolescents with a pre-pregnancy body mass index in the “normal”
range of 20.0 kg/m - 24.9 kg/m . This finding confirms prior studies that showed an
association between elevated body mass index and preeclampsia (23, 25, 29,56-59). In
these investigations, body mass index is used as a measure of relative obesity.
Obesity is characterized by expanded blood volume and increased cardiac output
(60). Additionally, excess weight increases the body’s oxygen consumption, leading to
an increase in stroke volume and cardiac output in an effort to meet the increased
metabolic demands. Hypertension likely results when the systemic vascular resistance
fails to decrease as cardiac output increases (60). In the context of this pre-existing
physiology in obese individuals, pregnancy increases cardiac output above this already
elevated baseline (56). Stone et al postulate that obese individuals may already be
maximally vasodilated early in pregnancy and are unable to compensate for the additional
increase in cardiac output resulting from pregnancy (56). While the body attempts to
sustain the increased blood flow, hypertension may develop and exacerbate the
endothelial injury and lead to the clinical sequela of preeclampsia (56).
Potter et al offer another explanation for the association between obesity and
preeclampsia (61). Their research showed that patients who develop preeclampsia have
increased levels of triglycerides when compared with controls (61). Endersen et al. also
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revealed that the sera of preeclamptic patients have a higher ratio of free fatty acids to
albumin and increased lipolytic activity when compared with the sera from
uncomplicated pregnancies (62). Additionally, the sera from these preeclamptic women
induced triglyceride accumulation in cultured endothelial cells with a reduction in
prostacyclin release. Wang J et al further showed that hyperlipidemic sera enhances
endothelial lipid peroxide production (63). Wang Y et al described the endothelial cell
damage that results from endothelial lipid peroxides and the subsequent vasoconstriction
and platelet aggregation the lipid peroxides promote (64). Stone et al postulated that
obesity-associated hyperlipidemia may directly or indirectly, through lipid peroxides,
damage maternal endothelial cells (56). Endothelial cell damage may contribute to the
severity of the preeclamptic process, thus explaining the association between obesity and
preeclampsia (56).
Prior studies have also subcategorized BMI in order to determine which
individuals are at the greatest risk of developing preeclampsia. Sibai et al examined a
cohort of healthy nulliparous women and found that the incidence of preeclampsia in this
population was 7.6% (58). The investigators divided the population into four groups:
BMI < 19.8 kg/m2, BMI 19.8 kg/m2 - 25.9 kg/rn2, BMI 26 kg/m2 - 34.9 kg/m2 and BMI >
35.0 kg/m . An increased incidence of preeclampsia was associated with an increase in
BMI as evidenced by an incidence of 4.3% in the group with BMI <19.8 kg/m2 and an
incidence of 12.6% in the group with a BMI of > 35 kg/rn". When these two extreme
groups were compared, the odds ratio was 3.22 for those with BMI >35 kg/m" versus
those with BMI <19.8 kg/m", suggesting that individuals with a BMI >35 were at least
three times more likely to develop preeclampsia than those with a BMI < 19.8 (58).

Von

24

Stallie et al also conducted a retrospective case-control study of severe preeclampsia (65).
They defined severe obesity as a BMI > 32.3 kg/m2 and found that a BMI > 32.3 kg/m2
was positively associated with preeclampsia, (OR: 3.5, 95% Cl: 1.68 - 7.46). Individuals
considered to have severe obesity by this definition were three times more likely to
develop preeclampsia than those with a BMI < 32.3 kg/m2 (65).
Wolfe et al also found that a maternal body mass index greater than the 90th
percentile for the individual was predictive of preeclampsia (OR: 2.26, 95% Cl: 1.712.99) (59). Interestingly, they noted that pre-pregnancy maternal weight was as
predictive of preeclampsia as pre-pregnancy BMI.

This finding led this research group

to assert that there is no additional advantage to calculating maternal BMI instead of
simply weighing the patient. Our study confirms this finding since both pre-pregnancy
weight and pre-pregnancy BMI were both positively associated with preeclampsia (OR
1.01, 95% Cl 1.00-1.02 and OR: 4.44, Cl: 1.03-1.18 respectively). Sibai et al also agreed
with this finding in their study that evaluated 2947 healthy women with a single fetus
(57). These women were prospectively followed from randomization at 13-27 weeks
gestation through delivery. Half of these women were given low dose aspirin while the
remainder received placebo. These investigators measured the relative pre-pregnancy
weight, calculated as a percentage of desired weight for height, of these subjects. The
relative pre-pregnancy weight was predictive of preeclampsia with a p value of <0.01
(57).
Mittendorf also reported that a pre-pregnancy BMI > 30 kg/m" was associated
with preeclampsia (OR: 2.7, 95% Cl: 1.6-4.4) (23). Chesley et al also found that severe
obesity is a risk factor for the development of preeclampsia; yet, he stated that this
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finding was present secondary to the confounding presence of chronic hypertension in his
population (66). Since our study excluded all patients with pre-existing chronic
hypertension, chronic hypertension is not a confounding factor in our study. Cnattingius
et al reported that the rate of preeclampsia among nulliparous women increased as body
mass index increased: the incidence of preeclampsia was 2.8% in lean women and 10.2%
in obese women (67). In this study, it appears that being in the underweight category was
actually protective against the development of preeclampsia. Although our study used
the same categories and values for underweight and obese women as Cnattingius et al.,
we did not find that women in the underweight category were protected against
preeclampsia.
Our current study differs from previous studies since we evaluated the risk of
increased pre-pregnancy BMI in women eighteen years old or younger. These previously
mentioned studies evaluated the influence of pre-pregnancy BMI on the risk of
preeclampsia in the general population, thus making no distinction between adolescents
and adults in the analysis. Additionally, previous studies have examined BMI as a risk
factor for adverse pregnancy outcomes such as early and late fetal death, preterm
delivery, and growth retardation instead of preeclampsia alone (67). Our study, however,
does have several limitations associated to our finding that high BMI is positively
associated with preeclampsia. For example, pre-pregnancy weight was abstracted from
the charts where it was initially obtained by patient report at the first prenatal visit. The
patients self reported their pre-pregnancy weight and so it is subject to recall bias. Pre¬
pregnancy weight was used as an individual variable as well as part of the calculation for
pre-pregnancy BMI, therefore subjecting pre-pregnancy BMI to this same recall bias.
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Additionally, our subjects were not divided into nulliparous and multiparous groups for
purposes of analysis nor were they analyzed within racial groups.
In addition to finding an association between elevated pre-pregnancy BMI and
preeclampsia in adolescents, this study also found a strong association between low
gynecologic and/or low chronologic age and the risk of developing preeclampsia. As
mentioned previously, this finding confirms many existing studies (40-44). Leppert et al
looked at the effect of maternal age on various birth outcomes (41). They noted that in a
group of 529 women aged 13-19 years there was a 6.6% incidence of preeclampsia while
there was an incidence of 2.6% in the 20-36 year old age group. Teenagers, therefore,
appear to be twice as likely to experience preeclampsia than women older than twenty
years of age (41). In a retrospective study comparing the pregnancy performance of 471
primigravid patients less than 15 years old with a control group of 471 primigravids
between 19-25 years old, Duenhoelter et al found that 34.2 % of the women less than 15
years of age developed preeclampsia whereas only 25.3% of the women in the older age
group did (p<0.01) (40). This study further supports the finding that younger mothers,
more specifically adolescents, are at increased risk for preeclampsia. Using information
from the National Hospital Discharge survey conducted by the National Center for Health
Statistics from 1979-1986, Saflas et al also noted that women less than 15 years old had a
2.8 fold higher risk of developing preeclampsia than women between 30-40 years of
age (5). In another retrospective case-control study, 9.9 % of the adolescents developed
preeclampsia while only 4% of the women aged 20-30 years did giving a p value of
<0.001 (42). Clark et al also looked at preeclampsia in adolescents and noted that 22.3%,
developed preeclampsia (6). They then found that although prenatal care helped decrease
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the incidence of preeclampsia from 22.3% to 11-13 % the incidence still remained high
(6). Satin et al. established that pregnant adolescents, younger than 17 years, had an
increased incidence of medical complications for both the mother and the fetus when
compared with older mothers (43). Additionally, the risks may be the greatest for the
youngest teenagers.
Although our study and the previously mentioned studies have shown evidence
that adolescents are at higher risk for preeclampsia than the general population, many
studies contradict this finding. For example, Berenson et al showed that there was not a
significant difference between the development of preeclampsia in pregnant women 1215 years old (9%) when compared to 16-17 year olds (9%) and 20-22 year olds (10%)
(45). They therefore concluded that young maternal age was not a risk factor for
preeclampsia (45). In this study, there were 147 nulliparous women in the group of 1215 year olds and nearly twice as many in the 16-17 year old group (45). This discrepancy
in the number of subjects in each group is most likely secondary to the smaller number of
women who deliver babies at an age less than 15 years. Given the small sample size in
the study population there may not have been adequate statistical power to detect a true
statistical difference in this population when compared to those aged 16-17 and those 2022 years old. Additionally, the patients in this study participated in specialized
adolescent programs that may have improved their prenatal care and thus helped decrease
the risk of preeclampsia.
Poma et al also did not find a significant difference in the incidence of
preeclampsia between primigravids <16 years old (14.6%) and primigravids greater than
20 years old (11.3%) (46). Hoff et al compared women 12-16.99 years old with women
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17-31 years old by race and found that there was not a significant difference between
adolescents and adults when compared within the same race (47). Other studies have
also shown that there is not a significant difference between the incidence of
preeclampsia in adolescents when compared to adults (48, 50-52). In the study
conducted by Osbourne et al, the investigators did not attempt to differentiate between
preeclampsia and other forms of hypertension (52). Felice et al. examined the correlation
between both the chronologic and gynecologic age and the frequency of preeclampsia
and did not find that those with a lower chronologic or gynecologic age were at increased
risk (49).
These discrepancies regarding whether adolescents are at increased risk of
preeclampsia likely results from differences in patient population, clinical care, or
methodologies. For example, these studies do not all use the same criteria for diagnosis
of preeclampsia. Felice et al define preeclampsia as a blood pressure greater than 140/90
or an increase in either systolic pressure by 20 mmHg or diastolic pressure by 15 nimHg
(49). Bozkaya et al define preeclampsia as two blood pressure readings greater than 90
mmHg measured twenty-four hours apart (42). Still other studies do not specify the
criteria they used for defining preeclampsia (6, 40, 46).
In addition to the lack of a uniform definition of preeclampsia in these studies,
there is not a consistent definition of young maternal age. Some studies define young
maternal age as individuals less than fifteen years old (5, 40, 45) while other studies
consider all individuals under nineteen to be of young maternal age (41). Regardless of
what age limit researchers choose for their studies, there is no clear definition explaining
why each age was chosen as the upper limit of young maternal age.
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At this time it is unclear how biologic immaturity may influence the risk of
preeclampsia. One possible explanation may be that the uterine vasculature is less well
developed in young women conceiving closer to menarche than in those with a higher
gynecologic age or further from menarche. Another possibility is that the uterus may
need repeated exposure to ovarian hormones, i.e. a specific number of cycles before
conception. Until it is clearer how biologic immaturity influences the risk of
preeclampsia, gynecologic age may represent a more accurate measure of a woman’s
biologic readiness for pregnancy than her chronologic age alone.
The results from our study also revealed that there was a positive association
between the amount of weight gained per week of pregnancy and the risk of developing
preeclampsia. As was previously mentioned, we feel that the weight gain per week of
pregnancy is a more sensitive and reliable risk factor to predict the development of
preeclampsia. Our finding of an association between the amount of weight gained during
pregnancy and the risk of developing preeclampsia confirms other studies (68-72). Over
a decade ago here at Yale, Shepard et al studied maternal weight gain as a proportion of
prepregnant weight to examine its relationship to complications experienced during
pregnancy, labor and delivery for healthy women. Women in this study did not have
preexisting chronic disease, were within their normal prepregnant weight for height and
delivered single infants without any congenital malformations between 37 to 42 weeks
(68). Their population included women aged 14 years and older. 11.6% of their study
population was 14-20 years old and the incidence of preeclampsia in their total
population was 3.6% (68). Shepard et al found that women with a proportional weight
gain greater than 35% had a fourfold risk of becoming preeclamptic when compared to
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women with weight gains in the range of 16% - 25% (relative risk =4.01,95%CI: 1.699.51) (68). They recommend that evaluating maternal weight gain in terms of a
proportion of prepregnant weight will be a better predictor of preeclampsia and other
complications of pregnancy than absolute maternal weight gain.
Building on the findings of Shepard et al and others (68-72) who showed a linear
relationship between weight gain and the development of preeclampsia, Theron and
Thompson attempted to use centile charts to screen for pregnancy complications. Their
goal was to improve the tools available to the clinician when evaluating an individual’s
risk, based on her weight gain, for developing preeclampsia based (70). Theron and
Thompson examined 1003 women with a singleton pregnancy for an association between
weight gain and pregnancy complications (70). They measured weight gain as the
average weight gain per week over the entire record. Weight gain was then divided into
four categories of equal frequency: < 0.33kg/week, > 0.33kg/week and <0.45 kg/week,
>0.45kg/week and <0.56kg/week, >0.56kg/week. The mean age of the women in the
study was 25.2 years (range 14-43 years). The incidence of preeclampsia in their
population was 7.3% (73/1003) (70). Although the incidence of preeclampsia increased
with increasing weight gain, Theron and Thompson found that excessive weight gain is
not an effective screening procedure for preeclampsia (70). A previous study by Redman
also confirms this finding (71).
A subsequent study by Theron and Thompson, examining the usefulness of
adaptive centiles for weight gain and sudden weight gain spurts in identifying those who
will develop preeclampsia, confirmed their earlier finding of an association between
preeclampsia and increased weight gain (72). In this study, Theron and Thompson
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examined the usefulness of a sudden weight gain spurt as a predictor of preeclampsia.
They concluded that a sudden weight gain spurt, defined as crossing centile bounds or
>0.9kg per week weight gain, is not a reliable sign of impending preeclampsia (72).
Although there appears to be an association between excessive weight gain and
preeclampsia, the usefulness of excessive weight gain to identify women who will
develop preeclampsia during pregnancy is often questioned. It is unlikely that the weight
gain itself causes the preeclampsia.

Additionally, it is difficult to determine if the

preeclampsia was preceded by sudden or gradual weight gain. Also, it is unclear if the
weight gain is actually fluid retention. If the weight gain is a marker of fluid retention
then this weight gain would be a result of preeclampsia itself and not a cause of it. In
order to be a useful screening tool, weight gain must antedate a rise in diastolic blood
pressure or the development of proteinuria. Additionally, as Chesley noted in his earlier
work, a sudden weight gain may be obscured unless observed over one or two weekly
periods (69). Since many pregnant adolescents have poor attendance in prenatal clinics,
leading to greater time periods between appointments, a sudden weight gain may be
missed. Currently, an effective means for incorporating weight gain as a screening
modality with a reasonable sensitivity and specificity does not exist. Until centiles for
weight gain with good sensitivity and specificity are developed, weight gain will remain
ineffective as a screening tool.
Although previous studies have found that UTI during pregnancy may place an
individual at greater risk for preeclampsia, in our study, UTI did not remain significant
after multiple logistic regression analysis (23,73,74). Hsu et al, however, did report that
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the women in their study who received magnesium sulfate had urinary catheterization, a
known risk factor for UTI, which may have been a possible confounding factor (73).
In summary, our study revealed that obesity prior to pregnancy, the amount of
weight gain per week of pregnancy, and biologic youth, as defined by low gynecologic
and chronologic age, are strong risk factors for the development of preeclampsia in
adolescents. Since it appears that obesity prior to pregnancy is a strong risk factor for the
development of preeclampsia in adolescent pregnancy, future research should focus on
strategies to normalize BMI before pregnancy in an effort to reduce the frequency of
preeclampsia. Future research should also investigate methods to incorporate weight gain
per week of pregnancy into a useful clinical tool that can assess the risk of preeclampsia
with improved sensitivity, specificity, and positive predictive value. Additionally,
continued laboratory research is necessary to help determine the possible relationship
between the pathophysiology of preeclampsia and biologic youth.

More research is still

needed to examine the possible association between urinary tract infections and
preeclampsia.
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Appendix A: Data Collection Form

Zip Code_
Study #_
Age at LMP_
Menarche_
Gynecologic Age_
G_P_
Service:_[University

Private

CHCP/YHP

Date of admission:_/_/_
Date of deliver}':_/_/_
Date of discharge:_/_/_

HROB

Hill]
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Prenatal Information
Race:_[African-American

Caucasian

Hispanic

ASian

Other _(list)]
Religion:_[None

Catholic

Protestant Jewish

Budhhist

Hindu

Muslim

Other _(list)]
LMP:
HDD:
EDD by LMP date:_Yes

_No

Earliest Ultrasound:_._weeks
P/T:_Yes

_No

Marital Status:_[Single

SEparated

Married

Divorced

Widowed ]

If married,

number of years in current marriage:_
Last grade completed:_[(13) for first year of college, etc.]
Education age -appropriate:_Yes
Employed:_Yes
Insurance:

_No

_No

_Unknown

_(name)

Contraceptive method as of LMP:_[None

BCPs

DepoProvera/Norplant

Diaphragm Condoms IUD]
Gestational age at first prenatal visit:_weeks
Prenatal Visit Number:_
Prepregnancy weight:_lbs/kg (circle)
1st visit height:_in/cm (circle)

weight:_lbs/kg (circle)

BMI: _

Weight at delivery:_Ibs/kg (circle)
Weight gain over pregnancy:_lbs/kg (circle) over_weeks
Smoker during pregnancy:_Yes

_No

_Unknown

If yes, number of cigarettes per day:_If quit, at what gestation:_wks
.Alcohol

"

"

:_Yes

_No

Amount:_
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Drugs

"

Crack cocaine

"

:_[None

Marijuana

IV Heroin

Other

IV cocaine

List:_ ]

Urine toxicology positive during this pregnancy:_Yes
[hist:_

Powder cocaine

_No

_Unknown

]

Caffeine use during pregnancy:_Yes

_No

Depression during pregnancy._Yes

_N o

Exercise during pregnancy:_Yes

_No

_Unknown

_Unknown

Amount_oz/d

Amount_min/d

Meds in pregnancy: _

Prenatal Hct: 1st_(_/_ /_)

last_(_/_/_)

One-hour GCT: _(_/_/_)
Blood Type:_[A

B

AB

Rh: _[Negative

Positive]

PPD:_[Negative

Positive

O]

Unknown]

Triple Screen (leave blank if not available):_._MOM (.AFT)
_._MOM (hCG)
_._MOM (Estriol)
Screen positive for:_Down Syndrome
HepBsAg:_[Negative

Positive]

Rubella:_[Nonimmune

Immune]

RPR: _[Nonreactive

_NTD

Reactive]

Blood pressures:_/_(first visit)_weeks
_/_(1st trimester, highest)

Highest SBP:_

_/_(2nd trimester, highest)

Highest SBP:_

__/_(3rd trimester, highest)

Highest SBP:_
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Bleeding during this pregnancy:_None
Hyperemsis gravidarum:_Yes
Gestational Diabetes: _Yes

First tri

Third tri

_No
_No

Ultrasound EFVV <10th%ile:_Yes

_No

_Unknown

STD during pregnancy (Circle any): Gonorrhea
cOndyloma Herpes

Second tri

Chlamydia

Trichomonas

Syphilis]

Bacterial vaginosis during pregnancy:_Yes

_No

Group B strep culture positive any time during current pregnancy' or delivery:_Yes
HIV:_[Negative
UTI:_Yes

Positive not Tested]

_No

Multiple gestation:_Yes(number of fetuses_)
Other antepartum complications:

Number of antepartum admissions:
Reasons:

_

_No

_

No
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Past Obstetric History
Number of previous induced/elective terminations of pregnancy:_
Number of previous first trimester miscarriages:_
Number of previous second trimester miscarriages:_
Years since last pregnancy:_
Breastfed: _Yes -_months

_No

Years of each birth (>24 weeks): 19_
19_
19_
19_
19_
History of previous pregnancy with:_[LBW
pReeclampsia/eclampsia

Congenital anomaly

PTD
Other

Stillbirth
List

Past Medical History
Preexisting diabetes:_Yes

_No

Preexisting or hypertension on 2 separate occasions less than 20 weeks:_Yes
Asthma:_Yes
HIV:_Yes

No
_No

_Unknown

Sickle Cell Disease:_Yes

_No

Hyperthyroidism: _Yes

_No

Renal disease:_Yes
SLE:_Yes

_No

_No

Antiphospholipid Syndrome:_Yes

_No

Operations:_Yes

List:___

_No

_N o
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History of Depression:_Yes

_No

Other Medical history:_Yes

_No

List:

Medications:

Family

History/Relationship:

_/_

39

Labor & Delivery
Gestational Age at delivery: _

_ (ld=_ _.14, 2d=_ _.29, 3d=__.43, 4d=__.57, 5d=__.71. 6d=__.86)

Neonatal number:_
PIH: _None

_Mild

_Severe

Superimposed on chronic hypertension:_Yes

_N o

Antepartum B/Ps:
Highest SBP:_Highest DBP:_
Lowest SBP:_Lowest DBP:_
Proteinuria:
Highest Dipstick:_Zero-trace

_+1

_+2 _+3 _+4

Highest 24hr protein:_gm
Criteria for Severe PIH:
SBP >160 mmHg:_Yes _No
DBP>110 mmHg:_Yes _No
Proteinuria >5g/24hr_Yes _No
Elevated serum Cr:_Yes
Eclampsia: _Yes

_No

_No

Pulmonary edema:_Yes

_No

Oliguria <500ml/24hr:_Yes

_No

Thrombocytopenia (<100K):_Yes
Elevated LFTs: _Yes
HELLP: _Yes
IUGR:_Yes

_No

_No

_No
_No

Oligohydramnios: _Yes

_No

Cerebral disturbances:_Yes
Visual disturbances:
Epigastric/RUQ pain:

Yes

_No

_No

Yes

No
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Therapy for preeclampsia:_MgSC4
_Labetalol

_Nifedipine

_Dilantin

_Aldomet

_Phenobarbital

_Hydralazine

_Other

Days from diagnosis to delivery:_days
Highest blood pressure in labor:_/_Highest SBP:
Induction:_Yes

No

If yes, reason:_[ Infection

Augmentation:_Yes

_No

Tracing abnormality

Preeclampsia

prolonged Rupture of membranes

Other

List: __

None given(5)]
Method(s) (circle any): PG gel Misoprostol
Epidural: _Yes

Cervidil Laminaria Pitocin

No

Cesarean section:

Yes

_No

If yes, indication (circle any):_[nonreassuring fetal Testing (tracing or pH)
labor Arrest

failed Instrument

Vaginal delivery:_Spontaneous
Tracing Abnormalities:_[None
decelerations

Elective

Forceps

Other

List__]

Vacuum

persistent nonReactive

persistent Late

Bradycardia]

Chorioamnionitis (fever/antibiotics/positive tap):_Yes
Abruption (retroplacental clot at delivery):_Yes

_No

Confirmed by placental pathology:_Yes

_No

Stillbirth: _Yes
Maternal mortality:

_No

_No
Yes

_No

Other complications in labor: _ _
Apgars: _(1 min)_(5 min)_(10 min)
Cord pH: _.

_(a)_._(v)_not obtained (0)

Postpartum Course
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Highest blood pressure:_/_Highest SBP:_
Postpartum complication (circle any): [None
Depression

Preeclampsia

Hemorrhage Fever

eClampsia

Other

Contraceptive choice(circle any): [None DepoProvera OCPs
NorpLant

IUD Foam/condoms

DiAphragm

Other

List:_]
Progesterone-only pill
List:_

Neonatal Course
Sex:_ [Male

Female]

Birth weight: _gm or_lbs _
Circle: AG A

SG4.

Morbidity:

oz

LGA

Positive blood cultures:_Yes

_No

[Pneumonia

Hyperbilirubinemia

Other

Mortality: _Yes

_No

Congenital anomaly:

Yes

Organism: _

RDS

BFD

List: _

_No

List:

Length of hospital stay: _days
Blood Type:_[A
Rh:_[Negative

B
Positive

Breastfeeding:_Yes
SIDS: _Yes

_No

_No

AB

NEC

O]

_

Endometritis

ivh
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